Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (121-130 of 315) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|April 26, 2025
Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantationPhuong Vo, Kevin Ng, Gary Schoch, et al.
Transplantation|May 23, 2013
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic targetMasahiko Sato, Rainer Storb, Carol Loretz, et al.
Transplantation|August 30, 2012
Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine modelScott S Graves, David W Mathes, George E Georges, et al.
Experimental Hematology|October 11, 2003
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioningMichael Maris, Michael Boeckh, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermatesWilliam J Hogan, Marie-Térèse Little, Eustacia Zellmer, et al.
Blood|April 29, 2004
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesMohamed L Sorror, Michael B Maris, Barry Storer, et al.
Transplantation|August 19, 2004
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation studyWolfgang A Bethge, D Scott Wilbur, Rainer Storb, et al.
Blood|August 18, 2005
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelLauri Burroughs, Marco Mielcarek, Marie-Térèse Little, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host DiseaseScott S Graves, Maura H Parker, Diane Stone, et al.
Transplantation|February 1, 2002
What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?Chang-Qing Xun, Marie-Térèse Little, Eustacia Zellmer, et al.
Pageof 32

Showing results (121-130 of 315) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|April 26, 2025
Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantationPhuong Vo, Kevin Ng, Gary Schoch, et al.
Transplantation|May 23, 2013
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic targetMasahiko Sato, Rainer Storb, Carol Loretz, et al.
Transplantation|August 30, 2012
Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine modelScott S Graves, David W Mathes, George E Georges, et al.
Experimental Hematology|October 11, 2003
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioningMichael Maris, Michael Boeckh, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermatesWilliam J Hogan, Marie-Térèse Little, Eustacia Zellmer, et al.
Blood|April 29, 2004
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesMohamed L Sorror, Michael B Maris, Barry Storer, et al.
Transplantation|August 19, 2004
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation studyWolfgang A Bethge, D Scott Wilbur, Rainer Storb, et al.
Blood|August 18, 2005
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelLauri Burroughs, Marco Mielcarek, Marie-Térèse Little, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host DiseaseScott S Graves, Maura H Parker, Diane Stone, et al.
Transplantation|February 1, 2002
What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?Chang-Qing Xun, Marie-Térèse Little, Eustacia Zellmer, et al.
Pageof 32